These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational study. Elriz K; Carrat F; Carbonnel F; Marthey L; Bouvier AM; Beaugerie L; Inflamm Bowel Dis; 2013 Aug; 19(9):1823-6. PubMed ID: 23702807 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling? Delaunoit T; Neczyporenko F; Limburg PJ; Erlichman C Am J Gastroenterol; 2005 Mar; 100(3):703-10. PubMed ID: 15743371 [TBL] [Abstract][Full Text] [Related]
4. The evolving management of small bowel adenocarcinoma. de Bree E; Rovers KP; Stamatiou D; Souglakos J; Michelakis D; de Hingh IH Acta Oncol; 2018 Jun; 57(6):712-722. PubMed ID: 29381126 [TBL] [Abstract][Full Text] [Related]
5. Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management. Gelsomino F; Balsano R; De Lorenzo S; Garajová I Curr Oncol; 2022 Feb; 29(2):1223-1236. PubMed ID: 35200603 [TBL] [Abstract][Full Text] [Related]
6. Rare but real: management of small bowel adenocarcinoma. Overman MJ Am Soc Clin Oncol Educ Book; 2013; ():189-93. PubMed ID: 23714497 [TBL] [Abstract][Full Text] [Related]
7. Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis. Chen FW; Sundaram V; Chew TA; Ladabaum U Clin Gastroenterol Hepatol; 2017 May; 15(5):728-737.e3. PubMed ID: 27856366 [TBL] [Abstract][Full Text] [Related]
8. Molecular Landscape of Small Bowel Adenocarcinoma. Pandya K; Overman MJ; Gulhati P Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267592 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. Overman MJ; Adam L; Raghav K; Wang J; Kee B; Fogelman D; Eng C; Vilar E; Shroff R; Dasari A; Wolff R; Morris J; Karunasena E; Pisanic TR; Azad N; Kopetz S Ann Oncol; 2018 Jan; 29(1):139-144. PubMed ID: 29069279 [TBL] [Abstract][Full Text] [Related]
10. Small bowel adenocarcinoma: Case reports and review of the literature. Manley J; Ibrahim Y; Ansell J; Alastal H; Rasheed A Arab J Gastroenterol; 2021 Sep; 22(3):240-245. PubMed ID: 34531134 [TBL] [Abstract][Full Text] [Related]
11. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Herrinton LJ; Liu L; Levin TR; Allison JE; Lewis JD; Velayos F Gastroenterology; 2012 Aug; 143(2):382-9. PubMed ID: 22609382 [TBL] [Abstract][Full Text] [Related]
12. Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features. Caio G; Volta U; Ursini F; Manfredini R; De Giorgio R BMC Gastroenterol; 2019 Mar; 19(1):45. PubMed ID: 30917787 [TBL] [Abstract][Full Text] [Related]
17. Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study. Svrcek M; Piton G; Cosnes J; Beaugerie L; Vermeire S; Geboes K; Lemoine A; Cervera P; El-Murr N; Dumont S; Scriva A; Lascols O; Ardizzone S; Fociani P; Savoye G; Le Pessot F; Novacek G; Wrba F; Colombel JF; Leteurtre E; Bouhnik Y; Cazals-Hatem D; Cadiot G; Diebold MD; Rahier JF; Delos M; Fléjou JF; Carbonnel F Inflamm Bowel Dis; 2014 Sep; 20(9):1584-92. PubMed ID: 25029614 [TBL] [Abstract][Full Text] [Related]
18. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from western Hungary 1977-2008. Lakatos PL; David G; Pandur T; Erdelyi Z; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Kiss LS; Lakatos L J Crohns Colitis; 2011 Apr; 5(2):122-8. PubMed ID: 21453881 [TBL] [Abstract][Full Text] [Related]
19. Small bowel adenocarcinoma of the jejunum: a case report and literature review. Li J; Wang Z; Liu N; Hao J; Xu X World J Surg Oncol; 2016 Jul; 14(1):177. PubMed ID: 27402105 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer. Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]